196 related articles for article (PubMed ID: 22195244)
1. Red cell distribution width: a novel marker of activity in inflammatory bowel disease.
Yeşil A; Senateş E; Bayoğlu IV; Erdem ED; Demirtunç R; Kurdaş Övünç AO
Gut Liver; 2011 Dec; 5(4):460-7. PubMed ID: 22195244
[TBL] [Abstract][Full Text] [Related]
2. Red cell distribution width for assessment of activity of inflammatory bowel disease.
Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
[TBL] [Abstract][Full Text] [Related]
3. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
[TBL] [Abstract][Full Text] [Related]
4. Value of red cell distribution width for assessing disease activity in Crohn's disease.
Hu D; Ren J; Wang G; Gu G; Li G; Liu S; Wu X; Chen J; Wu Q; Ren H; Hong Z; Li J
Am J Med Sci; 2015 Jan; 349(1):42-5. PubMed ID: 25171547
[TBL] [Abstract][Full Text] [Related]
5. The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease.
Chen YH; Wang L; Feng SY; Cai WM; Chen XF; Huang ZM
Gastroenterol Res Pract; 2020; 2020():3467419. PubMed ID: 32655630
[TBL] [Abstract][Full Text] [Related]
6. Can red cell distribution width be a marker of disease activity in ulcerative colitis?
Ipek S; Cekic C; Alper E; Coban E; Eliacik E; Arabul M; Aslan F; Vatansever S; Yalcin H; Unsal B
Int J Clin Exp Med; 2015; 8(8):13848-53. PubMed ID: 26550336
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
8. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
9. Can Red Cell Distribution Width Be Used as a Marker of Crohn's Disease Activity?
Oliveira AM; Cardoso FS; Rodrigues CG; Santos L; Martins A; de Deus JR; Reis J
GE Port J Gastroenterol; 2016; 23(1):6-12. PubMed ID: 28868424
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
11. Serum Albumin to Globulin Ratio is Associated with the Presence and Severity of Inflammatory Bowel Disease.
Wang Y; Li C; Wang W; Wang J; Li J; Qian S; Cai C; Liu Y
J Inflamm Res; 2022; 15():1907-1920. PubMed ID: 35313674
[TBL] [Abstract][Full Text] [Related]
12. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
[TBL] [Abstract][Full Text] [Related]
13. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
14. Serum α1-Antitrypsin Levels as a Marker of Activity in Pediatric Inflammatory Bowel Disease.
Pettei MJ; Levine JJ
Inflamm Bowel Dis; 1996; 2(3):168-72. PubMed ID: 23282561
[TBL] [Abstract][Full Text] [Related]
15. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
16. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
17. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease.
Oustamanolakis P; Koutroubakis IE; Messaritakis I; Kefalogiannis G; Niniraki M; Kouroumalis EA
J Crohns Colitis; 2011 Aug; 5(4):295-300. PubMed ID: 21683299
[TBL] [Abstract][Full Text] [Related]
18. Activity related increase of exhaled nitric oxide in Crohn's disease and ulcerative colitis: a manifestation of systemic involvement?
Koek GH; Verleden GM; Evenepoel P; Rutgeerts P
Respir Med; 2002 Jul; 96(7):530-5. PubMed ID: 12194639
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
20. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
